Literature DB >> 17563238

Defective implant osseointegration under protein undernutrition: prevention by PTH or pamidronate.

Romain Dayer1, Isabelle Badoud, René Rizzoli, Patrick Ammann.   

Abstract

UNLABELLED: Protein deficiency is associated with impaired titanium osseointegration. We studied whether systemic treatment with PTH or pamidronate could influence the resistance to pull-out of titanium rods implanted into rats proximal tibia under normal and isocaloric low protein intake. PTH or pamidronate prevented the deleterious effects of protein undernutrition on bone microarchitecture close to the implant and on mechanical fixation. PTH even significantly improved implant osseointegration.
INTRODUCTION: Protein deficiency is highly prevalent among elderly patients hospitalized in orthopedic wards. Reduced protein intake impairs titanium osseointegration in rats. Whether stimulator of bone formation or inhibitor of bone resorption could improve implant osseointegration under protein deprivation is not known. We studied the effects of systemic treatment with PTH or pamidronate on the resistance to pull-out of titanium rods implanted into rats proximal tibia under normal and isocaloric low protein intake.
MATERIALS AND METHODS: We measured the resistance to pull-out 1-mm-diameter titanium rods implanted into the proximal tibias of 49 adult female rats receiving a normal or an isocaloric low protein diet. After 2 wk on either diet, the implants were inserted, and the rats received PTH(1-34), pamidronate or saline vehicle for 8 wk. The tibias were removed for microCT morphometry, followed by the evaluation of pull-out strength.
RESULTS: Pull-out strength was lower in rats fed an isocaloric low protein diet compared with rats fed a normal protein intake (-29%). PTH and pamidronate significantly increased pull-out strength in animals fed a normal or a low protein diet, the effect of PTH being of higher magnitude. The PTH- or pamidronate-mediated increase in pull-out strength was associated with significant increases of relative bone volume, bone-to-implant contact, and trabecular thickness, whereas trabecular spacing was reduced, in the vicinity of the implants.
CONCLUSIONS: We confirmed that isocaloric low protein intake impairs titanium implant osseointegration. PTH or pamidronate prevented the deleterious effects of protein undernutrition and even significantly improved the implant osseointegration. These results indicate that systemic administration of PTH or pamidronate could be considered for preventing uncemented arthroplasty loosening in protein undernourished patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17563238     DOI: 10.1359/jbmr.070610

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  14 in total

Review 1.  Efficacy of parathyroid hormone supplementation on the osseointegration of implants: a systematic review.

Authors:  Fawad Javed; Mohammad D Al Amri; Sergio Varela Kellesarian; Abdulaziz A Al-Kheraif; Fahim Vohra; José Luis Calvo-Guirado; Hans Malmstrom; Georgios E Romanos
Journal:  Clin Oral Investig       Date:  2015-12-22       Impact factor: 3.573

2.  The effects of combined human parathyroid hormone (1-34) and simvastatin treatment on the interface of hydroxyapatite-coated titanium rods implanted into osteopenic rats femurs.

Authors:  Zhou-Shan Tao; Wan-Shu Zhou; Bing-li Bai; Wei Cui; Yang-Xun Lv; Xian-Bin Yu; Zheng-Liang Huang; Kai-kai Tu; Qiang Zhou; Tao Sun; Hang Li; Lei Yang
Journal:  J Mater Sci Mater Med       Date:  2016-01-12       Impact factor: 3.896

Review 3.  [Overview of animal researches about the effects of systemic drugs on implant osseointegration].

Authors:  Ya-Nan Wang; Ting-Ting Jia; Xin Xu; Dong-Jiao Zhang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-04-01

4.  Effects of combined human parathyroid hormone (1-34) and menaquinone-4 treatment on the interface of hydroxyapatite-coated titanium implants in the femur of osteoporotic rats.

Authors:  Hang Li; Qiang Zhou; Bing-Li Bai; She-Ji Weng; Zong-Yi Wu; Zhong-Jie Xie; Zhen-Hua Feng; Liang Cheng; Viraj Boodhun; Lei Yang
Journal:  J Bone Miner Metab       Date:  2017-12-26       Impact factor: 2.626

5.  Sclerostin antibody increases bone volume and enhances implant fixation in a rat model.

Authors:  Amarjit S Virdi; Min Liu; Kotaro Sena; James Maletich; Margaret McNulty; Hua Zhu Ke; Dale R Sumner
Journal:  J Bone Joint Surg Am       Date:  2012-09-19       Impact factor: 5.284

6.  Intermittent Parathyroid Hormone Enhances Cancellous Osseointegration of a Novel Murine Tibial Implant.

Authors:  Xu Yang; Benjamin F Ricciardi; Aleksey Dvorzhinskiy; Caroline Brial; Zachary Lane; Samrath Bhimani; Jayme C Burket; Bin Hu; Alexander M Sarkisian; F Patrick Ross; Marjolein C H van der Meulen; Mathias P G Bostrom
Journal:  J Bone Joint Surg Am       Date:  2015-07-01       Impact factor: 5.284

7.  Testing a novel nanofibre scaffold for utility in bone tissue regeneration.

Authors:  R Nicole Howie; Emily Durham; Brayden Oakes; Zachary Grey; Jason Smith; Phil Campbell; Amanda LaRue; Martin Steed; Robin Muise-Helmericks; James Cray
Journal:  J Tissue Eng Regen Med       Date:  2018-08-29       Impact factor: 3.963

8.  PTH improves titanium implant fixation more than pamidronate or renutrition in osteopenic rats chronically fed a low protein diet.

Authors:  R Dayer; T C Brennan; R Rizzoli; P Ammann
Journal:  Osteoporos Int       Date:  2009-10-27       Impact factor: 4.507

9.  The Impact of Nandrolone Decanoate in the Osseointegration of Dental Implants in a Rabbit Model: Histological and Micro-Radiographic Results.

Authors:  Saturnino Marco Lupi; Alessandra Nicole Sassi; Alessandro Addis; Ruggero Rodriguez Y Baena
Journal:  Materials (Basel)       Date:  2021-04-27       Impact factor: 3.623

10.  Systemic intermittent parathyroid hormone treatment improves osseointegration of press-fit inserted implants in cancellous bone.

Authors:  Henrik Daugaard; Brian Elmengaard; Troels Torp Andreassen; Anders Lamberg; Joan Elisabeth Bechtold; Kjeld Soballe
Journal:  Acta Orthop       Date:  2012-08-10       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.